The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
OpenAI raises $6.6B in Series C funding, reaches $157B valuation
OpenAI closes one of the largest funding rounds in history, raising $6.6 billion to accelerate AI research and expand global operations.
Neural Dynamics raises $850M Series D in September 2025 funding round
Neural Dynamics secures $850M in Series D funding in September 2025, reaching $12B valuation to advance its advanced neural interface technology for brain-computer communication.
Rentable secures $30M Series B for startup innovation
Rentable raises $30M in Series B funding to advance its property management software platform for apartment rentals and accelerate market growth.
AeroVault raises $600M Series D in September 2025 funding round
AeroVault secures $600M in Series D funding in September 2025, reaching $8.5B valuation to advance its space-based data storage and computing infrastructure platform.
RoboLogistics raises $320M Series C in September 2025 funding round
RoboLogistics secures $320M in Series C funding in September 2025, reaching $3.8B valuation to advance its autonomous warehouse robotics and fulfillment automation.
NeuroPharma raises $190M Series B in September 2025 funding round
NeuroPharma secures $190M in Series B funding in September 2025, reaching $1.6B valuation to advance its neurological drug discovery using ai and machine learning.
FlexiPay raises $290M Series C in September 2025 funding round
FlexiPay secures $290M in Series C funding in September 2025, reaching $4.1B valuation to advance its flexible payment platform for b2b transactions and cash flow management.
Quantum Shield raises $420M Series C in September 2025 funding round
Quantum Shield secures $420M in Series C funding in September 2025, reaching $5.8B valuation to advance its quantum-resistant cybersecurity platform for enterprise protection.
BioSynth Labs raises $380M Series B in September 2025 funding round
BioSynth Labs secures $380M in Series B funding in September 2025, reaching $3.2B valuation to advance its synthetic biology platform for sustainable chemical manufacturing.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.